人类免疫缺陷病毒(HIV)
肺结核
鉴别诊断
差速器(机械装置)
医学
病毒学
人工智能
机器学习
计算机科学
免疫学
病理
物理
热力学
作者
Ye Qiu,Zhengtu Li,Shi-xiong Yang,Wu-shu Chen,Yong Zhang,Qun-yu Kong,Ling-rui Chen,Jie Huang,Lin Lü,Kan Xie,Wen Zeng,Shaoqiang Li,Yangqing Zhan,Yan Wang,Jianquan Zhang,Feng Ye
标识
DOI:10.1016/j.jiph.2025.102740
摘要
BACKGROUND: Talaromyces marneffei is an emerging pathogen, and the number of infections in HIV-negative individuals is increasing. In HIV-negative individuals, talaromycosis is usually misdiagnosed as another disease, especially tuberculosis (TB). METHODS: We retrospectively extracted the clinical data of HIV-negative patients with Talaromyces marneffei infection from 2018 to 2023, analyzed the differences between TB patients and talaromycosis patients and attempted to establish differential diagnosis models utilizing clinical prediction models for these two diseases. RESULTS: Overall, 718 patients, including 137 patients with talaromycosis and 581 patients with pulmonary tuberculosis (PTB), were enrolled in this study. According to the multivariate analysis, age > 65 years, expectoration, and PLT count were independent predictors for TB. Fever, chest pain, gasping, rash, lymphadenectasis, osteolysis, Neu count, EOS count, and ALB were independent predictors for talaromycosis. Receiver operating characteristic (ROC) curve analysis of the training set showed that the area under the curve (AUC) (95 % CI) of the clinical differential model based on logistic regression analysis was 0.918 (0.884-0.953). The model was verified in the validation set. ROC curve analysis of the validation set showed that the AUC (95 % CI) was 0.900 (0.841-0.959). CONCLUSION: These new differential diagnosis models can calculate the probability of either talaromycosis or tuberculosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI